tk88 bet

Three COVID-19-related deaths confirmed on July 14 afternoon

The Ministry of Health on July 14 afternoon announced three COVID-19-related fatalities, raising the number of deaths in Vietnam to 135.
Three COVID-19-related deaths confirmed on July 14 afternoon ảnh 1Medical workers are disinfected after their shift in HCM City (Photo: VNA)
Hanoi (VNA) - The Ministry of Health on July 14 afternoon announced threeCOVID-19-related fatalities, raising the number of deaths in Vietnam to135.

The three were elderly with serious underlying diseases.

The first was patient No 21842, an 87-year-old woman living in District 8,Ho Chi Minh City. She suffered from hypertension and senility. She testedpositive for SARS-CoV-2 on July 4 and was treated at the HCM City Hospitalfor Tropical Diseases.

She died on July 10 and the cause of death was recordedas acute myocardial infarction, septic shock, severe pneumonia caused bySARS-CoV-2 infection in hypertensive patients and old age.

The second was also from HCM City. Patient No 27272 was a 67-year-old man.He suffered from cerebrovascular accident, chronic arthritisrequiring medical treatment.

He lived with his sonwho was positive for COVID-19. From June 17 to 27, he had a high fever, cough,and difficult breathing. He was quarantined for treatment at the Binh Chanh districthealth centre and tested positive for SARS-CoV-2. On June 27, he wastransferred to the HCM City Hospital for Tropical Diseases.

He died on July 10, withcause of death recorded as septic shock, skin infection, severe pneumoniadue to SARS-CoV-2 infection, multi-organ failure in patients withcerebrovascular accidents and chronic arthritis.

The last, patient 16223, was an83-year-old woman from Binh Thanh district in HCM City. She suffered fromhypertension, senile dementia, cerebrovascular accident and percutaneousgastrostomy.

On June 28-29, she developed a fever and cough, was admitted to the BinhThanh Hospital, tested positive for SARS-CoV-2 and was transferred to the HCMCity Hospital for Tropical Diseases.

She passed away on July12, with cause of death recorded as septic shock, severe pneumonia caused bySARS-CoV-2 infection in patients with hypertension, senility and myocardialinfarction./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🙈 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

ꦫ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

💛 Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|